emeis Société anonyme

Informe acción ENXTPA:EMEIS

Capitalización de mercado: €1.0b

emeis Société anonyme Resultados de beneficios anteriores

Pasado controles de criterios 2/6

emeis Société anonyme's earnings have been declining at an average annual rate of -25%, while the Healthcare industry saw earnings growing at 11.5% annually. Revenues have been growing at an average rate of 8.5% per year. emeis Société anonyme's return on equity is 76.3%, and it has net margins of 27%.

Información clave

-25.0%

Tasa de crecimiento de los beneficios

-51.7%

Tasa de crecimiento del BPA

Crecimiento de la industria Healthcare 13.4%
Tasa de crecimiento de los ingresos8.5%
Rentabilidad financiera76.3%
Margen neto27.0%
Última actualización de beneficios30 Jun 2024

Actualizaciones de resultados anteriores recientes

Recent updates

Should You Think About Buying Orpea SA (EPA:ORP) Now?

May 23
Should You Think About Buying Orpea SA (EPA:ORP) Now?

Orpea (EPA:ORP) May Have Issues Allocating Its Capital

Apr 18
Orpea (EPA:ORP) May Have Issues Allocating Its Capital

Why Orpea SA (EPA:ORP) Could Be Worth Watching

Jan 03
Why Orpea SA (EPA:ORP) Could Be Worth Watching

Orpea (EPA:ORP) Could Be Struggling To Allocate Capital

Nov 24
Orpea (EPA:ORP) Could Be Struggling To Allocate Capital

Orpea (EPA:ORP) Seems To Be Using A Lot Of Debt

Oct 18
Orpea (EPA:ORP) Seems To Be Using A Lot Of Debt

Is Now The Time To Look At Buying Orpea SA (EPA:ORP)?

Aug 25
Is Now The Time To Look At Buying Orpea SA (EPA:ORP)?

Orpea (EPA:ORP) Might Be Having Difficulty Using Its Capital Effectively

Aug 04
Orpea (EPA:ORP) Might Be Having Difficulty Using Its Capital Effectively

Desglose de ingresos y gastos

Cómo gana y gasta dinero emeis Société anonyme. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).


Historial de beneficios e ingresos

ENXTPA:EMEIS Ingresos, gastos y beneficios (EUR Millions)
FechaIngresosBeneficiosGastos G+AGastos de I+D
30 Jun 245,4301,46900
31 Mar 245,3141,41200
31 Dec 235,1981,35500
30 Sep 235,062-1,38700
30 Jun 234,926-4,12800
31 Mar 234,803-4,07800
31 Dec 224,681-4,02700
30 Sep 224,602-2,16700
30 Jun 224,524-30700
31 Mar 224,411-12100
31 Dec 214,2996500
30 Sep 214,19312700
30 Jun 214,08818900
31 Mar 214,00517500
31 Dec 203,92216000
30 Sep 203,86317600
30 Jun 203,80419200
31 Mar 203,77221300
31 Dec 193,74023400
30 Sep 193,66123100
30 Jun 193,58122700
31 Mar 193,50122400
31 Dec 183,42022000
30 Sep 183,35623000
30 Jun 183,29223900
31 Mar 183,21516400
31 Dec 173,1389000
30 Sep 173,06213300
30 Jun 172,98617600
31 Mar 172,91423500
31 Dec 162,84129400
30 Sep 162,74522000
30 Jun 162,65014700
31 Mar 162,52113700
31 Dec 152,39212700
30 Sep 152,28612800
30 Jun 152,18013000
31 Mar 152,06412600
31 Dec 141,94912100
30 Sep 141,83211200
30 Jun 141,71610300
31 Mar 141,66210800
31 Dec 131,60811400

Ingresos de calidad: EMEIS has a high level of non-cash earnings.

Margen de beneficios creciente: EMEIS became profitable in the past.


Análisis del flujo de caja libre vs. Beneficios


Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: EMEIS has become profitable over the past 5 years, growing earnings by -25% per year.

Acelerando crecimiento: EMEIS has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Beneficios vs. Industria: EMEIS has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (12.1%).


Rentabilidad financiera

Alta ROE: Whilst EMEIS's Return on Equity (76.34%) is outstanding, this metric is skewed due to their high level of debt.


Rentabilidad económica


Rendimiento del capital invertido


Descubre empresas con buenos resultados en el pasado